Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARMUSTINE vs CASIRIVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARMUSTINE vs CASIRIVIMAB: Safety Overview

Metric CARMUSTINE CASIRIVIMAB
Total FAERS Reports 3,376 500
Deaths Reported 781 24
Death Rate 23.1% 4.8%
Hospitalizations 873 209
Average Patient Age 52.0 yrs 58.9 yrs
% Female Patients 33.8% 52.4%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Amneal Pharmaceuticals LLC N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A